I have Appealed the FOIA Denial of NIAID/Remdesivir Clinical Trials Data.
Full text of the appeal letter follows.
August 13, 2023
Gorka Garcia-Malene
FOIA Officer National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892 V
Dear FOIA Officer Garcia-Malene,
I hereby appeal your decision to deny my Freedom of Information Act request number: 60211. The basis for my appeal has three sections.
First: The stated basis you used to deny my appeal is contrary to the intent and language of the Freedom of Information Act.
Second: There is a compelling and urgent need to inform the public of protocols subsidized by the Federal Government that have led to unnecessary deaths in hospitals. The data in the NIAID Remdesivir trials could potentially demonstrate that the government knew medical practices used in the NIAID trials needlessly caused death. Exposing this information could save lives in the future.
Third: There is a conflict of interest within the NIAID to expose the truth due to the large amounts of needless deaths already generated by the hospital protocols using Remdesivir, ventilators, and opioids. These needless deaths potentially form a criminal liability for NIAID employees such as Anthony Fauci.
ILLEGAL BASIS FOR DENIAL
Your basis for denying my request violates the spirit and the text of the Freedom of Information Act (hereafter referred to as the “Act”).
The Act requires each Federal Agency to set up a system to allow members of the public to access whatever data is subject to reporting requirements in the Act.
You claim that “the NIAID is not able to segregate the requested data from the PII and is not required under the FOIA to incur expense to do so through the data management contractor.”
Your statement has two fallacies: 1). That the NIAID is not able to segregate data; and 2). That the NIAID is not required to incur expense to meet the requirements of the Act.
Addressing the first fallacy: “... the NIAID is not able to segregate the requested data from the PII ...” In fact, the NIAID does have the ability to segregate data such as personally identifiable information (PII). The “Data Science” section of the NIAID’s website establishes that the NIAID has data science technology and expertise that far exceeds the ability to redact PII such as the names, ages and genders from data sets of patients who have participated in NIAID clinical trials. (1)
Addressing the second fallacy: “... the NIAID ... is not required under the FOIA to incur expense to do so through the data management contractor.”
It is implicit in the Act that Federal Agencies will incur expenses to meet the requirements of the Act. To my knowledge, Congress has never denied funding to a Federal Agency to meet the requirements of their own Acts of Congress. Your salary of $176,300 in fiscal year 2022, Mr. Garcia-Malene, as an “Freedom of Information Act Officer” of the NIH, is a necessary expense to meet the requirements of the Act, for instance. (2)
Although the Act does not prohibit an Agency from outsourcing their data management services, the Act does not allow a Federal Agency to circumvent the requirements of the Act by contracting their data management to a third party while refusing to access or make necessary redactions to their own data because they would have to incur an expense from an unidentified third party- "the data management contractor.”
The Freedom of Information Act requires government agencies subject to the Act to meet the requirements of the Act. The Act is Law, and as an Information Act Officer of the NIH, you are required to obey the Law of the United States.
COMPELLING AND URGENT NEED TO INFORM THE PUBLIC
It is not possible to overstate the compelling need of performing a proper statistical analysis of the data generated by the NIAID Remdesivir clinical trials. Large numbers of Medical professionals, journalists, and family members of those killed in hospitals believe that hospital protocols were directly responsible for the bulk of mortality in hospitals that was falsely and deceptively ascribed to the “COVID” disease.
The data from the NIAID’s Remdesivir trials may serve to prove or disprove these concerns of the public. Further, as I stated in my request for expedited processing, which was also denied without proper cause, a proper statistical analysis of the data from the NIAID Remdesivir clinical trials could prevent needless deaths in hospitals in the future.
Supporting the concerns of the public, a study published by Feinberg School of Medicine provided evidence that ventilators were a driver of deaths falsely ascribed to “COVID." (3). I requested data on ventilators among other things.
Mr. Garcia-Malene, I beg you to consider the large amount of needless deaths already created by malpractice, and the amount of deaths that you could possibly save by releasing the requested data from the NIAID Remdesivir trials.
CONFLICT OF INTEREST WITHIN THE NIAID
The NIAID reported that large amounts of patients died in both the “Placebo” and “Remdesivir” groups of the NIAID Remdesivir clinical trials. All cause mortality in the NIAID Remdesivir trials #NCT04280705 was 77/521 (14.78%) in the “Placebo” group, and 59/541 (10.91%) in the “Remdesivir” group. (4)
On the other hand, numerous doctors have reported survival rates of thousands of “COVID” at or near 100%, suggesting that whatever was done to the NIAID Remdesivir clinical trial participants led to their deaths via malpractice. If any NIAID employees would like to argue with that statement, I should be allowed to have the complete data set from the NIAID Remdesivir clinical trials (with redacted PII) to use in my argument.
Countless citizens have accused Anthony Fauci of murder for his involvement in the Emergency Use Authorization of Remdesivir based on the NIAID clinical trials results that clearly showed needlessly high death rates. Assuming NIAID Remdesivir trials data can be used to demonstrate that Anthony Fauci should have known that Remdesivir and related protocols would lead to needless deaths deceptively blamed on “COVID,” the NIH/NIAID clearly has a conflict of interest in suppressing or releasing their data, as this data could potentially be used against Anthony Fauci in criminal proceedings.
Other employees within the NIH/NIAID should consider that by suppressing Remdesivir clinical trials data, they could potentially be considered accessories to any crimes that could be demonstrated with the data. NIAID employees should also consider that they may be held liable for protocol deaths going forward if they suppress information necessary to inform the public of the deadly protocols.
Respectfully,
Charles Wright
REFERENCES
(1). https://www.niaid.nih.gov/research/data-science
(2). https://www.federalpay.org/employees/national-institutes-of-health/ garcia-malene-gorka
(3). https://news.feinberg.northwestern.edu/2023/05/05/secondary- bacterial-pneumonia-drove-many-covid-19-deaths/
(4). https://classic.clinicaltrials.gov/ct2/show/results/NCT04280705
You hit a "bull's eye" with that letter, Charles, in my humble, non-lawyer opinion! I thank you on behalf of all the Remdesivir victims & their families. God Bless!
That is awesome.